bca total protein content assay (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
99
Structured Review
Thermo Fisher
bca total protein content assay
Bca Total Protein Content Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bca+total+protein+content+assay/BCA+Protein+Assay+Kit/pm36989421-41-35-34
Average 99 stars, based on 1 article reviews
Bca Total Protein Content Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bca+total+protein+content+assay/BCA+Protein+Assay+Kit/pm36989421-41-35-34
Average 99 stars, based on 1 article reviews
bca total protein content assay - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Luciferase:Article Title: Targeting the Urokinase Plasminogen Activator Receptor with Synthetic Self-Assembly Nanoparticles Article Snippet: Imperial College Genetic Therapies Centre, Department of Chemistry, Flowers Building, Armstrong Road, Imperial College London, London SW7 2AZ, United Kingdom, Department of Organic Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, Toernooiveld 1Huygens Building 03.016, 6525 ED Nijmegen, The Netherlands, and ImuThes Ltd, Flowers Building, Armstrong Road, London SW7 2AZ, United Kingdom.. Received May 13, 2008; Revised Manuscript Received November 18, 2008 Article Title: Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles Article Snippet: The decoration of nanoparticle surfaces with receptor-specific ligands can improve the delivery of their therapeutic load to cancer cells.. Using as the ligand, U11, a peptide specific for the cancer-associated urokinase plasminogen activator receptor, we examined the effect of manipulation of nanoparticle properties on the targeting specificity of U11-nanoparticles.. The nanoparticle surface charge was controlled by varying the amount of the cationic lipid within the nanoparticle formulation. Reporter Gene Assay:Article Title: Targeting the Urokinase Plasminogen Activator Receptor with Synthetic Self-Assembly Nanoparticles Article Snippet: Imperial College Genetic Therapies Centre, Department of Chemistry, Flowers Building, Armstrong Road, Imperial College London, London SW7 2AZ, United Kingdom, Department of Organic Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, Toernooiveld 1Huygens Building 03.016, 6525 ED Nijmegen, The Netherlands, and ImuThes Ltd, Flowers Building, Armstrong Road, London SW7 2AZ, United Kingdom.. Received May 13, 2008; Revised Manuscript Received November 18, 2008 Article Title: Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles Article Snippet: The decoration of nanoparticle surfaces with receptor-specific ligands can improve the delivery of their therapeutic load to cancer cells.. Using as the ligand, U11, a peptide specific for the cancer-associated urokinase plasminogen activator receptor, we examined the effect of manipulation of nanoparticle properties on the targeting specificity of U11-nanoparticles.. The nanoparticle surface charge was controlled by varying the amount of the cationic lipid within the nanoparticle formulation. Lysis:Article Title: Targeting the Urokinase Plasminogen Activator Receptor with Synthetic Self-Assembly Nanoparticles Article Snippet: Imperial College Genetic Therapies Centre, Department of Chemistry, Flowers Building, Armstrong Road, Imperial College London, London SW7 2AZ, United Kingdom, Department of Organic Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, Toernooiveld 1Huygens Building 03.016, 6525 ED Nijmegen, The Netherlands, and ImuThes Ltd, Flowers Building, Armstrong Road, London SW7 2AZ, United Kingdom.. Received May 13, 2008; Revised Manuscript Received November 18, 2008 Article Title: Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles Article Snippet: The decoration of nanoparticle surfaces with receptor-specific ligands can improve the delivery of their therapeutic load to cancer cells.. Using as the ligand, U11, a peptide specific for the cancer-associated urokinase plasminogen activator receptor, we examined the effect of manipulation of nanoparticle properties on the targeting specificity of U11-nanoparticles.. The nanoparticle surface charge was controlled by varying the amount of the cationic lipid within the nanoparticle formulation. MTT Assay:Article Title: Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake Article Snippet: .. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), SYBR Safe DNA gel stain, DNA ladder, siRNA loading buffer and E-Gel EX gels, phenol red reagents, GAPDH siRNA (anti-GAPDH and negative siRNA), and KDALERT Ambion GAPDH gene assay kit and Pierce Article Title: Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake. Article Snippet: .. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), SYBR Safe DNA gel stain, DNA ladder, siRNA loading buffer and E-Gel EX gels, phenol red reagents, GAPDH siRNA (anti-GAPDH and negative siRNA), and KDALERT Ambion GAPDH gene assay kit and Pierce Staining:Article Title: Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake Article Snippet: .. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), SYBR Safe DNA gel stain, DNA ladder, siRNA loading buffer and E-Gel EX gels, phenol red reagents, GAPDH siRNA (anti-GAPDH and negative siRNA), and KDALERT Ambion GAPDH gene assay kit and Pierce Article Title: Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake. Article Snippet: .. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), SYBR Safe DNA gel stain, DNA ladder, siRNA loading buffer and E-Gel EX gels, phenol red reagents, GAPDH siRNA (anti-GAPDH and negative siRNA), and KDALERT Ambion GAPDH gene assay kit and Pierce Gene Assay:Article Title: Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake Article Snippet: .. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), SYBR Safe DNA gel stain, DNA ladder, siRNA loading buffer and E-Gel EX gels, phenol red reagents, GAPDH siRNA (anti-GAPDH and negative siRNA), and KDALERT Ambion GAPDH gene assay kit and Pierce Article Title: Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake. Article Snippet: .. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), SYBR Safe DNA gel stain, DNA ladder, siRNA loading buffer and E-Gel EX gels, phenol red reagents, GAPDH siRNA (anti-GAPDH and negative siRNA), and KDALERT Ambion GAPDH gene assay kit and Pierce Negative Control:Article Title: Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake Article Snippet: .. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), SYBR Safe DNA gel stain, DNA ladder, siRNA loading buffer and E-Gel EX gels, phenol red reagents, GAPDH siRNA (anti-GAPDH and negative siRNA), and KDALERT Ambion GAPDH gene assay kit and Pierce Article Title: Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake. Article Snippet: .. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), SYBR Safe DNA gel stain, DNA ladder, siRNA loading buffer and E-Gel EX gels, phenol red reagents, GAPDH siRNA (anti-GAPDH and negative siRNA), and KDALERT Ambion GAPDH gene assay kit and Pierce Plasmid Preparation:Article Title: Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles Article Snippet: The decoration of nanoparticle surfaces with receptor-specific ligands can improve the delivery of their therapeutic load to cancer cells.. Using as the ligand, U11, a peptide specific for the cancer-associated urokinase plasminogen activator receptor, we examined the effect of manipulation of nanoparticle properties on the targeting specificity of U11-nanoparticles.. The nanoparticle surface charge was controlled by varying the amount of the cationic lipid within the nanoparticle formulation. |